At the 56th European Dialysis & Transplantation Association congress in Budapest, June 2019, Allmed signed a supply agreement with Asahi Kasei Medical Co., Ltd. (hereinafter referred to as “Asahi”), to manufacture and supply Endotoxin Retention Filters (ETRFs) across a worldwide territory.
Allmed’s filter will serve as the exclusive ETRF dedicated to Asahi’s latest dialysis machine, Reliedia®.
Allmed’s ETRF range, the Allmed SafeFlow®, is validated for the purification of the water supply feed into Reliedia® for Haemodialysis and Haemodia filtration therapies.
Commenting on the signature, Roberto Saracco, Chief Commercial Officer of Allmed Group has said “We are very pleased with this announcement, enabling Allmed to utilise its core filtration expertise to support Asahi’s new dialysis machine.”
Allmed is a vertically-integrated producer of end-to-end haemodialysis product solutions, committed to delivering world class patient-centred dialysis therapies.
Asahi Kasei Medical, one of the operating companies in the Health Care Sector of Asahi Kasei Group
* Reliedia is a registered trademark of Asahi Kasei Medical Co., Ltd. in EU.
* Allmed SafeFlow is a registered trademark of Allmed in the EU